SEC Form 4 · accession 0001400482-16-000220
KUBOTA PHARMACEUTICAL HOLDINGS CO LTD · M??????
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Edward H Danse
Officer — Chief Business Officer
Period of report
Aug 18, 2016
Accepted (ET)
Aug 18, 2016 · 6:53 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001400482
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 18, 2016 | M | 75,101 | $5.48 | A | 181,493 | D | |
| Common StockF1,F2 | Aug 18, 2016 | S | 75,101 | $10.81 | D | 106,392 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F3,F4,F1 | $5.48 | Aug 18, 2016 | M | 75,101 | D | — | May 1, 2025 | Common Stock | 75,101 | 165,222 | D |
Explanation of responses
- F1The issuer's common stock trades on the Tokyo Stock Exchange under the symbol referenced in the issuer's registration statement on Form S-1 (File No. 333-192900).
- F2The shares were sold at a price of 1082 Japanese Yen. The U.S. per share price in this Column 4 reflects the average of the buy and sell Japanese Yen-to U.S. Dollar exchange rates on the transaction date divided by the number of shares sold. These shares were sold in multiple transactions at prices ranging from 1054 to 1120 Japanese Yen, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- F3The exercise price of the stock options is the closing price of the Issuer's common stock on May 7, 2015, which is the first trading day of the Issuer's common stock on the Tokyo Stock Exchange following the May 1, 2015 grant date.
- F4Twenty-five percent (25%) of the shares subject to the option vest on 5/1/2016, and the remaining 75% of the shares subject to the option vest on a monthly basis over the following three years, with 100% vested and exercisable on 5/1/2019, subject to the optionee's provision of service to the Issuer on each such vesting date.